Cargando...

Denosumab treatment in the management of patients with advanced prostate cancer: clinical evidence and experience

Osteoprotective therapies have become an essential component in the management of advanced prostate cancer (PC) patients as bone metastases (BMs) have a major impact on morbidity and mortality. Denosumab is a fully humanized antibody targeting the receptor activator of nuclear factor κB ligand (RANK...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ther Adv Urol
Main Authors: Hegemann, Miriam, Bedke, Jens, Stenzl, Arnulf, Todenhöfer, Tilman
Formato: Artigo
Idioma:Inglês
Publicado: SAGE Publications 2017
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5378096/
https://ncbi.nlm.nih.gov/pubmed/28392837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287216686018
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!